Ekaterine Berishvili studied medicine in Tbilisi, Georgia, where she obtained her medical degree (1999) and then her doctorate in science (2003), while also training in general surgery (2005). She then switched to a career in scientific research and was appointed Associate Professor at Tbilisi Medical University in 2008. From the outset of her career in Georgia, she collaborated with international experts—notably at the Albert Einstein College of Medicine (New York) and the Diabetes Research Institute (Miami)—which enabled her to establish her own laboratory and define her line of research in the field of pancreatic bioengineering and cell therapy for type 1 diabetes, which would earn her international recognition. In addition to her commitment to fundamental and translational university research, she also served as director of clinical research and head of the cell isolation and transplantation unit in the Department of Cell Technologies and Therapies (2010–2014).

She joined the University of Geneva in 2014, where she continued her scientific career. Since 2020, she has been group leader at the Tissue Engineering and Organ Regeneration Laboratory (Department of Surgery) and, since 2023, technical director of the HUG Islet Isolation and Transplantation Laboratory – the only facility in Switzerland with a dedicated laboratory. Her career has been marked by numerous international collaborations, significant funding (H2020, SNSF, JDRF), and publications in high-impact journals. She sits on the scientific committee of the Swiss Transplant Cohort Study, is a member of the Swisstransplant Islet-Pancreas Working Group, and is secretary of the European Society for Organ Transplantation (ESOT).